Yang Xiaoqing, Lin Baohua, Shen Tong
Pediatrics Department, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China.
Xiamen Maternal and Child Health Care Hospital, Xiamen, China.
Front Pediatr. 2023 Mar 23;11:1123941. doi: 10.3389/fped.2023.1123941. eCollection 2023.
To understand the renal damage and clinical features of pediatric patients with acute Epstein-Barr virus (EBV) infection.
In this retrospective observational study, 548 pediatric patients who were admitted to and treated at the Xiamen Women and Children Health Center between January 2017 and December 2021 and who met the criteria of acute EBV infection were selected as participants. The sociodemographic and clinical data of these patients were collected for statistical analysis. The study population was divided into a renal damage group (41 patients) and a non-renal damage group (507 patients), and the characteristics of the two groups were compared.
(1) Of the 548 enrolled patients, 340 and 208 were boys and girls, respectively. Among them, 41 patients showed renal damage (renal damage group), including 26 boys and 15 girls, and the incidence rate of renal damage was 7.48%. (2) The major renal involvements in the 41 pediatric patients with acute EBV infection in the renal damage group manifested as hematuria (56.1%), proteinuria (37.71%), hematuria + proteinuria (12.9%), edema (51.22%), hypertension (17.07%), oliguria (4.88%), and acute renal failure (2.44%). (3) The pediatric patients in the renal damage group had statistically significantly longer fever durations, higher blood EBV-DNA loads, and lower blood CD4/CD8 T lymphocyte ratios than those in the non-renal damage group.
In pediatric patients, the incidence rate of acute EBV-induced renal damage is not low. The clinical manifestations are mostly hematuria or proteinuria, with an overall good prognosis, but occasionally severe renal damage such as acute renal failure. The possibility of secondary renal damage is high when pediatric patients with acute EBV have prolonged fever, high blood EBV-DNA loads, and decreased blood CD4/CD8 ratios.
了解儿童急性爱泼斯坦-巴尔病毒(EBV)感染的肾脏损害及临床特征。
在这项回顾性观察研究中,选取2017年1月至2021年12月期间在厦门市妇幼保健院住院治疗且符合急性EBV感染标准的548例儿童患者作为研究对象。收集这些患者的社会人口学和临床数据进行统计分析。将研究人群分为肾脏损害组(41例)和无肾脏损害组(507例),比较两组的特征。
(1)在548例入选患者中,男孩340例,女孩208例。其中,41例患者出现肾脏损害(肾脏损害组),包括男孩26例,女孩15例,肾脏损害发生率为7.48%。(2)肾脏损害组41例急性EBV感染儿童患者的主要肾脏受累表现为血尿(56.1%)、蛋白尿(37.71%)、血尿+蛋白尿(12.9%)、水肿(51.22%)、高血压(17.07%)、少尿(4.88%)和急性肾衰竭(2.44%)。(3)肾脏损害组儿童患者的发热持续时间在统计学上显著长于无肾脏损害组,血液EBV-DNA载量更高,血液CD4/CD8 T淋巴细胞比值更低。
在儿童患者中,急性EBV所致肾脏损害的发生率不低。临床表现多为血尿或蛋白尿,总体预后良好,但偶尔会出现如急性肾衰竭等严重肾脏损害。急性EBV感染的儿童患者发热时间延长、血液EBV-DNA载量高且血液CD4/CD8比值降低时,继发肾脏损害的可能性较高。